Document is current
Any future updates will be listed below
-
Authors
Fan, Zhiguo
Li, Duocai
Yan, Shi
Zhao, Xianzhi
Yin, Lei
Xu, Weidong
Wang, Ye
Zhang, Huojun
Chang, Yifan
Ren, Shancheng
-
Funding
Funding for this research was provided by:
2022 Shanghai Top Priority Research Center Construction Program ((2022ZZ01011))
2022 National Natural Science Fund ((Youth Fund, No.82203138, YC))
2021 Changhai Hospital Educational Sponsorship Fund ((CHPY2021B24, General Program, YC))
2021 Naval Medical University Basic Science Research Youth Start-up Fund ((2021QN29, YC))
2024 Changzheng Hospital Investigator-initiated Clinical Research Program ((incubation program, 2023YJBF-FH01, SR))
- License Information
-
More Information
Article History
Received: 11 August 2024
Accepted: 14 November 2024
First Online: 24 April 2025
Declarations
:
: The study protocol, along with any amendments, informed consent, and the patient information brochure, underwent thorough review and received approval. Ethical approval for this study has been granted by the review committee (CHEC2022-226) and has been documented with the ethics committees of the participating centers. The study will be conducted in strict adherence to local laws and regulations, following the ethical principles outlined in the Declaration of Helsinki, and in accordance with the Good Clinical Practice (GCP) principles for clinical trials.
: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
: Potential participants will be notified by the urologist. Informed consent(Supplementary Material S1) will be obtained from all participants and co-signed by the clinician providing the patient information.
: The authors declare no competing interests.
